XR 5967

modulates plasminogen activator inhibitor-1; an angiogenesis inhibitor and possible antineoplastic agent; structure in first source

Also Known As:

XR-5967; XR5967

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/2004 - "XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro."
2.	Fibrosarcoma 01/01/2004 - "XR5967 dose-dependently inhibited the invasion of human HT1080 fibrosarcoma cells through Matrigel. "

1.	Plasminogen Activators (Plasminogen Activator)
2.	matrigel